Streetbeat News

CRLBF

Cresco Labs Inc.

http://www.crescolabs.com/

CEO

Charles Bachtell

Employees

3,500

Industry

Medicinal and Botanical Manufacturing

Open

0.98

Mkt cap

357M

Volume

333K

High

1.02

P/E Ratio

-5.56

52-wk high

2.65

Low

0.96

Div yield

N/A

52-wk low

0.96

The US cannabis sector has seen a recent pullback due to market volatility and regulatory concerns, creating potential buying opportunities for undervalued stocks. Despite short-term challenges, the long-term outlook remains positive, with the market expected to exceed $41 billion by 2025.

Portfolio Pulse from

December 12, 2024 | 3:15 pm

The marijuana industry is poised for potential growth in 2025, with expectations of reduced volatility and increased momentum in marijuana stocks. Comprehensive reform and relaxed policies could significantly advance the industry.

Portfolio Pulse from

December 04, 2024 | 2:30 pm

The US cannabis industry is showing resilience with a projected growth from $30 billion to over $50 billion by 2030. Recent stock pullbacks present investment opportunities, especially with federal legalization efforts gaining momentum. Investors are advised to use technical analysis for informed decisions.

Portfolio Pulse from

November 17, 2024 | 3:45 pm

Cresco Labs Inc. (CRLBF) reported a Q3 loss of $0.02 per share, missing the Zacks Consensus Estimate of a $0.01 loss. This is an improvement from the $0.04 loss per share a year ago.

Portfolio Pulse from

November 09, 2024 | 1:00 am

Cresco Labs Inc. held its Q3 2024 earnings conference call, discussing financial performance and company developments.

Portfolio Pulse from

November 08, 2024 | 3:15 pm

Cresco Labs has reported its third quarter 2024 financial results, highlighting the success of its cash flow-focused strategy.

Portfolio Pulse from

November 08, 2024 | 12:15 pm

Microsoft shares rise as the company reports better-than-expected Q1 2025 GAAP EPS and sales.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 8:05 pm

On October 29, 2024, several cannabis-related stocks experienced significant price movements. Currenc Group (NASDAQ:CURR) and Encompass Health (NYSE:EHC) were among the gainers, while Eastside Distilling (NASDAQ:EAST), 22nd Century Group (NASDAQ:XXII), Cara Therapeutics (NASDAQ:CARA), Greenlane Holdings (NASDAQ:GNLN), and Urban-gro (NASDAQ:UGRO) were among the losers.

Portfolio Pulse from Benzinga Insights

October 29, 2024 | 8:30 pm

Florida's cannabis market is poised for significant changes with the upcoming recreational cannabis vote. The market is experiencing deflation, with sales dropping despite volume growth, and a competitive landscape is emerging. Key players like Trulieve, Verano, and AYR are expanding retail operations, while M&A activity is expected to increase. Companies like AYR and iAnthus may become acquisition targets due to financial challenges, while others like Green Thumb and Curaleaf are positioned to acquire assets. If recreational cannabis is legalized, the market could triple, offering substantial growth opportunities.

Portfolio Pulse from Nicolás Jose Rodriguez

October 26, 2024 | 6:15 pm

MariMed is expanding its cannabis operations in Illinois, aiming to boost growth despite market challenges. The company is focusing on capacity expansion and in-house brand performance. MariMed's stock has underperformed compared to the MSOS ETF, but recent gains suggest potential growth.

Portfolio Pulse from Nicolás Jose Rodriguez

October 25, 2024 | 3:51 am

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.